View in EDS HTML Full Text PDF Full Text

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease.

Saved in:
Bibliographic Details
Title: Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease.
Authors: Ashton, Nicholas J. (AUTHOR), Di Molfetta, Guglielmo (AUTHOR), Tan, Kübra (AUTHOR), Blennow, Kaj (AUTHOR), Zetterberg, Henrik (AUTHOR), Messing, Albee (AUTHOR)
Source: Neurological Sciences. Sep2024, Vol. 45 Issue 9, p4513-4518. 6p.
Subjects: Glial fibrillary acidic protein, Gain-of-function mutations, Cytoplasmic filaments, Body fluids, Cerebrospinal fluid
Abstract: Introduction: Alexander disease (AxD) is a rare leukodystrophy caused by dominant gain-of-function mutations in the gene encoding the astrocyte intermediate filament, glial fibrillary acidic protein (GFAP). However, there is an urgent need for biomarkers to assist in monitoring not only the progression of disease but also the response to treatment. GFAP is the obvious candidate for such a biomarker, as it is measurable in body fluids that are readily accessible for biopsy, namely cerebrospinal fluid and blood. However, in the case of ASOs, the treatment that is furthest in development, GFAP is the target of therapy and presumably would go down independent of disease status. Hence, there is a critical need for biomarkers that are not directly affected by the treatment strategy. Methods: We explored the potential utility of biomarkers currently being studied in other neurodegenerative diseases and injuries, specifically neurofilament light protein (NfL), phosphorylated forms of tau, and amyloid-β peptides (Aβ42/40). Results and Conclusions: Here, we report that GFAP is elevated in plasma of all age groups afflicted by AxD, including those with adult onset. NfL and p-tau are also elevated, but to a much lesser extent than GFAP. In contrast, the levels of Aß40 and Aß42 are not altered in AxD. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 178877895
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ashton%2C+Nicholas+J%2E%22">Ashton, Nicholas J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Molfetta%2C+Guglielmo%22">Di Molfetta, Guglielmo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tan%2C+Kübra%22">Tan, Kübra</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blennow%2C+Kaj%22">Blennow, Kaj</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zetterberg%2C+Henrik%22">Zetterberg, Henrik</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Messing%2C+Albee%22">Messing, Albee</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Sep2024, Vol. 45 Issue 9, p4513-4518. 6p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Glial+fibrillary+acidic+protein%22">Glial fibrillary acidic protein</searchLink><br /><searchLink fieldCode="DE" term="%22Gain-of-function+mutations%22">Gain-of-function mutations</searchLink><br /><searchLink fieldCode="DE" term="%22Cytoplasmic+filaments%22">Cytoplasmic filaments</searchLink><br /><searchLink fieldCode="DE" term="%22Body+fluids%22">Body fluids</searchLink><br /><searchLink fieldCode="DE" term="%22Cerebrospinal+fluid%22">Cerebrospinal fluid</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Introduction: Alexander disease (AxD) is a rare leukodystrophy caused by dominant gain-of-function mutations in the gene encoding the astrocyte intermediate filament, glial fibrillary acidic protein (GFAP). However, there is an urgent need for biomarkers to assist in monitoring not only the progression of disease but also the response to treatment. GFAP is the obvious candidate for such a biomarker, as it is measurable in body fluids that are readily accessible for biopsy, namely cerebrospinal fluid and blood. However, in the case of ASOs, the treatment that is furthest in development, GFAP is the target of therapy and presumably would go down independent of disease status. Hence, there is a critical need for biomarkers that are not directly affected by the treatment strategy. Methods: We explored the potential utility of biomarkers currently being studied in other neurodegenerative diseases and injuries, specifically neurofilament light protein (NfL), phosphorylated forms of tau, and amyloid-β peptides (Aβ42/40). Results and Conclusions: Here, we report that GFAP is elevated in plasma of all age groups afflicted by AxD, including those with adult onset. NfL and p-tau are also elevated, but to a much lesser extent than GFAP. In contrast, the levels of Aß40 and Aß42 are not altered in AxD. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=178877895
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-024-07495-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 4513
    Subjects:
      – SubjectFull: Glial fibrillary acidic protein
        Type: general
      – SubjectFull: Gain-of-function mutations
        Type: general
      – SubjectFull: Cytoplasmic filaments
        Type: general
      – SubjectFull: Body fluids
        Type: general
      – SubjectFull: Cerebrospinal fluid
        Type: general
    Titles:
      – TitleFull: Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ashton, Nicholas J.
      – PersonEntity:
          Name:
            NameFull: Di Molfetta, Guglielmo
      – PersonEntity:
          Name:
            NameFull: Tan, Kübra
      – PersonEntity:
          Name:
            NameFull: Blennow, Kaj
      – PersonEntity:
          Name:
            NameFull: Zetterberg, Henrik
      – PersonEntity:
          Name:
            NameFull: Messing, Albee
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1